Literature DB >> 8827563

Ophthalmological issues in the neurofibromatoses.

B R Korf1.   

Abstract

The neurofibromatoses are a set of at least two distinct disorders characterized by the development of nerve sheath tumors and diverse other features. Both are genetically determined as autosomal dominant traits, and both genes have been identified, with resultant major insights into pathogenesis. The neurofibromatoses have prominent effects on the visual system, which are important both for diagnosis and clinical management. This review focuses on clinical aspects of the neurofibromatoses, highlighting ophthalmological issues and recent advances in molecular genetics.

Entities:  

Mesh:

Year:  1996        PMID: 8827563     DOI: 10.3928/0191-3913-19960701-12

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  5 in total

1.  Electro-oculogram in patients with neurofibromatosis type 1.

Authors:  W Lubiński; S Zajaczek; Z Sych; K Penkala; O Palacz; J Lubiński
Journal:  Doc Ophthalmol       Date:  2001-09       Impact factor: 2.379

Review 2.  Ophthalmological manifestations in VHL and NF 1: pathological and diagnostic implications.

Authors:  Klaus-Martin Kreusel
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

3.  Supernormal electro-oculograms in patients with neurofibromatosis type 1.

Authors:  Wojciech Lubiński; Stanisław Zajaczek; Zbigniew Sych; Krzysztof Penkala; Olgierd Palacz; Jan Lubiński
Journal:  Hered Cancer Clin Pract       Date:  2004-09-15       Impact factor: 2.857

4.  Neurofibromatosis type 2: a case of ptosis.

Authors:  L Cotticelli; M Romano; S Russo; M Borrelli
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-03-09       Impact factor: 3.117

5.  Neurofibromatosis Type 2 Presenting with Oculomotor Ophthalmoplegia and Distal Myopathy.

Authors:  Jessica Mani Penny Tevaraj; Evelyn Tai Li Min; Raja Azmi Mohd Noor; Azhany Yaakub; Wan Hazabbah Wan Hitam
Journal:  Case Rep Ophthalmol Med       Date:  2016-09-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.